With inflation, energy shocks and bond yields all in focus, many investors are looking for companies that are not only surviving the noise but also backed by strong fundamentals. A solid balance sheet and high return on equity can help show which businesses are using capital efficiently while keeping financial risk in check. That is exactly what the Solid Balance Sheet and Fundamentals screener is built to highlight. In this article, you will see three stocks filtered by that approach, along with a clear breakdown of why their financial quality may appeal if you are trying to stay disciplined while markets remain unpredictable.

Monster Beverage (MNST)

Overview: Monster Beverage is a global drinks company that develops, markets, and sells a wide range of energy drinks and related beverages, from its flagship Monster Energy and zero sugar lines to ready to drink coffees, teas, juices, and alcoholic drinks, distributed through retailers, bottlers, and e commerce across multiple regions.

Operations: Monster generates most of its revenue from Monster Energy Drinks at about US$7.7b, with additional contributions from Strategic Brands at roughly US$468.7m, Alcohol Brands at about US$134.7m, and Other at around US$25.0m.

Market Cap: US$75.5b

Monster Beverage stands out in this screener because its strong brands, broad zero sugar lineup, and international reach are tied to robust fundamentals, including high return on equity and net margins around 23%. Recent results show double digit earnings growth, record quarterly sales above US$2.1b, and solid demand outside the U.S. In addition, partnerships and cost controls support its ability to keep profitability resilient. At the same time, a rich P/E multiple, rising costs, and questions around long term energy drink category growth mean the bar for future performance is high. For investors, the key consideration is how that quality growth profile and these risks come together in the current valuation story.

Monster Beverage’s high returns and rich P/E hint that something in the story may be getting misread. Before deciding the bar is too high, review the DCF valuation analysis for Monster Beverage and see what the valuation implies about one crucial pressure point.

Exelixis (EXEL)

Overview: Exelixis is a U.S. based oncology company that develops and sells cancer medicines such as CABOMETYX and COMETRIQ for difficult to treat tumors, while also advancing a broad pipeline of targeted therapies and antibody drug conjugates aimed at expanding treatment options for patients.

Operations: Exelixis generates about US$2.3b in biotechnology revenue, with the vast majority coming from the U.S. at roughly US$2.1b and smaller contributions from Europe at about US$154.2m and Japan at around US$25.6m.

Market Cap: US$11.1b

Exelixis attracts attention because it pairs oncology earnings with a solid balance sheet and returns on equity, while trading on P/E multiples below many biotech peers. CABOMETYX remains the workhorse. The zanzalintinib program in colorectal cancer and other solid tumors could reshape the product mix if regulators grant approval, particularly after a rival’s kidney cancer trial setback shifted attention toward Exelixis. At the same time, reliance on a single drug, margin pressure from discounted 340B sales, insider selling and high executive pay highlight the key risks. The key consideration is how this balance of cash generation and pipeline uncertainty compares when you look beyond headline numbers.

Oncology cash flow paired with a broad pipeline often hides what really matters for Exelixis valuation today. Get the full picture in the 4 key rewards and 1 important warning sign, including one underappreciated twist that could change the story abruptly.

Palantir Technologies (PLTR)

Overview: Palantir Technologies builds software platforms that help governments and companies pull together huge amounts of data, make sense of it, and act on it, particularly in areas like defense, security, and complex industrial operations. Its tools power everything from military situational awareness to AI driven decision making in sectors such as automotive, aerospace, energy, and financial services.

Operations: Palantir generates about US$2.4b from Government customers and roughly US$2.1b from Commercial clients, with total revenue of around US$4.5b.

Market Cap: US$348.9b

Palantir sits at the intersection of defense, data and AI, with platforms like Gotham, Foundry and the Artificial Intelligence Platform now embedded in long term programs such as the Pentagon’s Maven Smart System and multi year partnerships with groups like Stellantis, GE Aerospace and LG. Earnings growth of 251.6% over the past year, a 36.3% net margin and high return on equity indicate why some investors are willing to pay a premium. However, that valuation level, along with reliance on government contracts and higher risk external funding, means expectations are tight. A key consideration is whether its role as an AI operating system for both governments and enterprises can justify that pricing over time, or whether current optimism may be overlooking important risks.

Palantir’s surging earnings and premium pricing hint that the full AI story is still not fully priced in. See how the analyst forecasts for Palantir Technologies lines up with its government reliance and one risk almost everyone is glossing over.

The three stocks in this article are just a starting point, with the full screener surfacing 38 more companies that share high return on equity, resilient past performance and solid balance sheets through the Solid Balance Sheet and Fundamentals screener. Use Simply Wall St to identify and analyze the specific catalysts and narratives that matter most to you so you can focus on the highest conviction opportunities for your portfolio.

Take Control of Your Investment Journey

If Palantir Technologies or any of these companies sound like a great opportunity, register for FREE with Simply Wall St and add your top picks to a Watchlist to monitor the share price against the fair value for the ideal entry point. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.

Curious About Exploring Fresh Alternatives?

Fresh ideas do not stay under the radar for long, and the next breakout list could be flying before most investors notice, so move while it still matters and act now.

• Spot income workhorses before yields start dropping by scanning a curated pool of potential high payout opportunities through the 13 dividend fortresses.
• Catch future AI leaders while they are still building momentum by zeroing in on companies powering real profitability inside the 73 profitable AI stocks that aren't just burning cash.
• Ride structural demand for electricity without getting caught chasing late movers by tracking grid enablers selected in the 33 power grid technology and infrastructure stocks.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.